PateƱo, Cecile P.
HRN: 28-90-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/29/2026
04/29/2026
IVT
1g
Single Dose
Herniated Nucleus Pulposus L4 L5
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines